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Summary
 
Killer cell inhibitory receptors and CD94-NKG2-A/B heterodimers are major histocompati-
bility complex class I–specific inhibitory receptors expressed by natural killer cells, T cell anti-
gen receptor (TCR)-
 
g
 
/
 
d
 
 cells, and a subset of TCR-
 
a
 
/
 
b
 
 cells. We studied the functional in-
teraction between TCR-
 
g
 
/
 
d
 
 and CD94, this inhibitory receptor being expressed on the
majority of 
 
g
 
/
 
d
 
 T cells. When engaged by human histocompatibility leukocyte antigen class I
molecules, CD94 downmodulates activation of human TCR-
 
g
 
/
 
d
 
 by phosphorylated ligands.
CD94-mediated inhibition is more effective at low than at high doses of TCR ligand, which
may focus T cell responses towards antigen-presenting cells presenting high amounts of anti-
gen. CD94 engagement has major effects on TCR signaling cascade. It facilitates recruitment
of SHP-1 phosphatase to TCR–CD3 complex and affects phosphorylation of Lck and ZAP-70
kinase, but not of CD3 
 
z
 
 chain upon TCR triggering. These events may cause abortion of
proximal TCR-mediated signaling and set a higher TCR activation threshold.
 
A
 
ctivation of NK cells is modulated by inhibitory receptors
that interact with MHC class I molecules. The MHC
class I–binding receptors currently identified have been as-
signed to two distinct groups that belong to the Ig (killer
inhibitory receptors; KIR) and C-type lectin superfamilies
(CD94), which here are collectively referred to as inhibitory
receptors (IR). The p58.1, p58.2, p70, and the p70/140 KIRs
recognize different supertypic epitopes of HLA-C, HLA-B,
and HLA-A isoforms (for reviews see references 1–4). The
second type of IR includes heterodimers of CD94 covalently
associated with NKG2-A or NKG2-B molecules (5, 6). Both
CD94 and NKG2 molecules are type II membrane glycopro-
teins that belong to the superfamily of C-type lectins. These
receptors have a broader specificity in that they recognize dif-
ferent HLA-A, -B, and -C alleles (for review see reference 2).
KIRs inhibit cell triggering through recruitment and ac-
tivation of intracellular phosphatases (for reviews see refer-
ences 7 and 8), via a mechanism similar to that regulating B
cells (9). The natural substrates of these phosphatases are
not known and it is believed that they inhibit proximal ty-
rosine kinase activation (7, 8).
Surface expression of KIRs is not limited to NK cells,
since T cells with TCR-
 
a
 
/
 
b
 
 or -
 
g
 
/
 
d
 
 are also KIR
 
1
 
. Only
a limited number of TCR-
 
a
 
/
 
b
 
 cells express p58.1, p58.2,
and p70 KIR (10–12), and preferential expression of KIRs
has been reported on CD45RO
 
1
 
 CD29
 
1
 
 memory cells
 
(13). Based on these findings, it was proposed that KIRs are
expressed by T cells after chronic cell activation and after
generation of long-lived memory cells (2). It has also re-
cently been reported that p70 KIR may inhibit activation
of TCR-
 
a
 
/
 
b
 
 by bacterial superantigens (11, 14) and by
melanoma antigen (15).
Little is known about the functional role of IR on
TCR-
 
g
 
/
 
d
 
 T cells. Phenotypic studies showed that 
 
z
 
60%
of circulating 
 
g
 
/
 
d
 
 T cells are CD94
 
1
 
 (16). In contrast, ex-
pression of the p58 and p70 KIRs on 
 
g
 
/
 
d
 
 T cells is rare
(12, 14, 17, 18). This study shows that CD94 finely down-
modulates TCR-
 
g
 
/
 
d
 
 activation induced by phosphorylated
metabolites (19–21), as 
 
g
 
/
 
d
 
 T cell response is severely im-
paired in the presence of low, but not high, doses of ligand.
This regulation correlates with increased recruitment of
SHP-1 to CD94 and to the TCR–CD3 complex, with re-
duced Lck–TCR–CD3 complex association, and with
ZAP-70 kinase hypophosphorylation.
 
Materials and Methods
 
T Cell Clones, Lines, and Phosphorylated Ligands.
 
T cell lines
and clones were established and maintained as previously de-
scribed (22). Isopentenylpyrophosphate (IPP) was purchased from
Sigma Chemical Co. (Buchs, Switzerland). Daudi cells were pur-
chased from the American Type Culture Collection (Rockville,
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g
 
/
 
d
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MD), and 
 
b
 
2-microglobulin gene–transfected Daudi cells (Daudi-
 
b
 
2) were provided by Dr. J. Parnes (Stanford University, Stan-
ford, CA; reference 23).
 
Immunofluorescence Analysis.
 
The following mAbs were used:
B1 (IgG1) anti-pan TCR-
 
g
 
/
 
d
 
; B3 (IgG1) anti-V
 
g
 
9; 4A11 (IgG1)
anti-V
 
g
 
4; 4G6 (IgG1) anti-V
 
d
 
2 (all characterized in our labora-
tory); 
 
d
 
TCS1 (IgG1) anti-V
 
d
 
1-J
 
d
 
1/2 (Endogen, Boston, MA);
P11.5B (IgG1) anti-V
 
d
 
3 (provided by Dr. M. Bonneville, IN-
SERM Unité 211, Nantes, France); Q66 (IgM) anti-p140 (pro-
vided by Dr. L. Moretta, Laboratorio di Immunopatologia, Gen-
ova, Italy); GL183 (IgG1) anti-p58.2; HP3B1 (IgG2a) anti-CD94
(Immunotech, Marseilles, France); 5.133 (IgG1) anti-p140 and
p70 (24); and HP3E4 (IgM) anti-p58.1 (provided by Dr. M. Ló-
pez-Botet, Hospital de la Princesa, Madrid, Spain). Three-color
immunofluorescence analysis was performed using anti-TCR
mAbs together with two anti-IR mAbs, when the isotype of the
antibodies could be combined. First antibodies were revealed
with mouse Ig isotype-specific FITC-, PE-, or biotin-labeled
goat antisera (Southern Biotechnology Associates, Birmingham,
AL) and streptavidin-3 color (Caltag, San Francisco, CA). A
FACScan
 
“
 
 flow cytometer with the Lysis II program was used for
acquisition and analysis of data.
 
Cytokine Release Assays.
 
T cells (5 
 
3
 
 10
 
4
 
/well) were stimu-
lated by phosphorylated ligands in duplicate cultures in flat-bot-
tomed 96-well plates in the presence of different types of APC
(5 
 
3
 
 10
 
4
 
/well). After 18 h of incubation, 100 
 
m
 
l of supernatant
was removed and used to test the content of TNF-
 
a
 
 by ELISA
using commercial kits (Endotell, Bottmingen, Switzerland).
 
Killing Assays.
 
Cytotoxic assays were performed as previously
described (25).
 
Immunoprecipitation and Western Blot Analyses.
 
The following
mAbs were used for immunoprecipitation and immunoblotting
analysis: anti-CD3 
 
z
 
 chain; anti-Lck and anti–SHP-1 antibodies
(Santa Cruz Biotechnology, Santa Cruz, CA); anti–ZAP-70 and
antiphosphotyrosine 4G10 (Upstate Biotechnology, Lake Placid,
NY); and H146-968 hamster mAbs which recognize human CD3 
 
z
 
chain (a gift of Dr. R. Kubo, Cytel Corp., San Diego, CA). Im-
munoprecipitation was performed using 
 
g
 
/
 
d
 
 T cells (5 
 
3
 
 10
 
6
 
/ml)
incubated with Daudi cells (8 
 
3
 
 10
 
6
 
/ml) in the presence of IPP at
37
 
8
 
C for 30 min. To better detect the inhibitory effects of CD94
on 
 
g
 
/
 
d
 
 TCR, a suboptimal dose of IPP (10 
 
m
 
M) was used. Cells
were washed twice in cold PBS at 4
 
8
 
C and then maintained for
40 min at 4
 
8
 
C in lysis buffer (1% digitonin, or 1% NP-40, 150 mM
NaCl, 20 mM Tris-HCl, pH 7.2, containing 1 mM sodium ortho-
vanadate, 2 mM EDTA, 1 mM NaF, 1 mM PMSF, 10 
 
m
 
g/ml leu-
peptin, and 10 
 
m
 
g/ml aprotinin). After centrifugation at 10,000 
 
g
 
 for
15 min, supernatants were precleared with protein G–Sepharose
beads (Pharmacia Biotech Europe, Dubendorf, Germany), and then
with mouse Ig coupled to protein G–Sepharose, and then superna-
tants were incubated with indicated mAb–protein G–Sepharose at
4
 
8
 
C for 3 h. Immunoprecipitates were washed three times with 1 ml
of 0.3% digitonin or NP-40 buffer and solubilized in Laemmli’s sam-
ple buffer. Immunoblot analysis was performed as previously described
(25). The presence of NKG2A was confirmed by PCR amplifica-
tion and by detection of an 
 
z
 
44-kD band with an anti-NKG2A
antiserum in anti-CD94 immunoprecipitates (data not shown).
 
Results and Discussion
 
The Majority of Human TCR-
 
g
 
/
 
d
 
 Cells Express at least
One IR.
 
Using five different IR-specific mAbs, analysis of
IR expression was performed on a panel of 
 
g
 
/
 
d
 
 T cell
clones isolated from different donors and tissues. As shown
in Fig. 1, most of the 
 
g
 
/
 
d
 
 clones derived from peripheral
blood were positive for at least one mAb, thus demonstrat-
ing that, in contrast to what has been reported for 
 
ab
 
 T
cells (1–3, 16), IR are often expressed on the surface of 
 
g
 
/
 
d
 
T cells. CD94 was the most frequently expressed IR, with
27 
 
g
 
/
 
d
 
 clones positive out of the 40 tested. A smaller num-
ber of clones (15 out of 40) were p58.1, p58.2, p70, or
p140 KIRs positive. Since all clones were activated under
the same conditions and CD94
 
2
 
 clones maintained a stable
phenotype, it is unlikely that CD94 expression was induced
during culture. Phenotypic comparison of clones bearing
different types of V
 
g
 
/V
 
d
 
 pairs revealed the tendency for
V
 
g
 
9 (TCRVG2S1)/V
 
d2 (TCRDV102S1) cells to be
CD941 more frequently than cells using other Vg and Vd
chains, without reaching a statistically significant difference.
The six CD41 g/d clones tested were negative for all the
anti-KIR mAbs (data not shown). They might represent a
distinct population of g/d T cells with different TCR reg-
ulatory mechanisms. The same analysis performed on seven
g/d clones derived from the thymus revealed only two
positive clones. Conversely, all 12 g/d clones from the in-
testine were CD941, and 6 of them coexpressed KIRs. Al-
though we analyzed a limited number of clones, these re-
sults suggest that the expression of IR varies in different
organs.
Coexpression of p140 and CD94, or p58.1 and CD94,
was studied on total g/d T cells freshly isolated from nine
donors (Fig. 2) or on subpopulations bearing different Vd
chains (data not shown). These analyses showed that CD94
is the most frequently expressed IR and that only a minor-
ity of g/d T cells express p140 and p58.1 KIRs, thereby
confirming the results obtained with g/d clones. The ex-
pression of KIRs seemed to be biased because in some do-
nors all the p1401 g/d T cells were CD941, while in oth-
ers p1401 g/d T cells were all CD942. These findings
could result from an oligoclonal expansion, as described for
KIRs1 ab T cells (13).
Figure 1. Distribution of inhibi-
tory receptors on g/d clones derived
from PBMC, thymus, and gut. Im-
munofluorescence analyses were
performed on 40 clones from
PBMC, 7 from thymus, and 12 from
intestine using anti-CD94, and anti-
p58.1, p58.2, p70, and p140 KIR
mAbs (see Materials and Methods).
The area of each pie is proportional
to the number of clones reactive
with CD94 or KIR-specific anti-
bodies. Clones reactive with at least
one KIR Ab were grouped and indi-
cated as KIR1.1771 Carena et al. Brief Definitive Report
Taken together, our phenotypic analysis indicates that
expression of CD94 and KIRs by g/d T cells is not ran-
dom, and it suggests that the microenvironment in which
T cells are activated influences expression of IR.
CD94 Modulates TCR-g/d Activation. As most of Vg9/
Vd2 cells express at least the CD94 molecule, we investi-
gated the inhibitory capacity of this IR on TCR-g/d acti-
vation. Daudi Burkitt’s lymphoma cell line, which does not
express the b2-microglobulin gene and is therefore HLA
class I2, is killed by g/d T cells bearing the Vg9/Vd2 TCR
(26). We first studied whether killing of Daudi cells by
CD941 Vg9/Vd2 cells could be inhibited by CD94 en-
gagement with HLA class I molecules. When Vg9/Vd2
cells were tested against b2-microglobulin gene–transfected
Daudi cells (Daudi-b2; reference 23), which express HLA
class I molecules on the surface, killing was reduced but
could be partially restored by addition of anti-CD94 mAbs
(data not shown). Thus, like KIRs (11, 12, 14, 17, 18),
CD94 also inhibits TCR activation.
Human g/d T cells also react to a variety of nonpeptidic
ligands, some of which are phosphorylated metabolites
(19–21). We studied whether TCR-g/d activation by IPP,
a strong agonist ligand (20, 21), could be inhibited by
CD94. g/d clones were stimulated with different doses of
IPP in the presence of Daudi or Daudi-b2 cells as APCs
and TNF-a release was measured. The results confirmed
that HLA class I1 APCs greatly reduce TCR-g/d–medi-
ated cell activation (Fig. 3, A and B). TNF-a release was
partially restored by addition of anti-CD94 mAbs, but not
by isotype-matched irrelevant mAb (Fig. 3, C and D), thus
further supporting the involvement of CD94. More impor-
tantly, CD94 engagement shifted the dose–response curve
towards higher amounts of ligand. In the presence of
Daudi-b2 APCs, 5–20 times higher doses of IPP were re-
quired than in the presence of Daudi APCs for an equiva-
lent TNF-a release. This effect was consistently observed
with four additional g/d clones (data not shown). These
findings suggest that CD94 might serve the function of set-
ting a higher cell activation threshold, as shown for other
lymphocyte surface molecules (27).
Engagement of CD94 by HLA Class I Molecules Increases
Recruitment of SHP-1 Phosphatase to CD94 and to the TCR–
CD3 Complex and Causes Tyrosine Hypophosphorylation. The
inhibitory activities of KIRs have been ascribed to mem-
brane recruitment of phosphatases and subsequent dephos-
phorylation of Lck, ZAP-70, and phospholipase C-g (28).
We tested whether SHP-1 phosphatase, which has been
coprecipitated with the NKG2-A/NKR-P1C chimeric re-
ceptor (29), associates with CD94 expressed by g/d T cells.
Indeed, SHP-1 was associated with CD94 in g/d T cells
stimulated with IPP and the amount of coprecipitated
SHP-1 was increased in the presence of Daudi-b2 APCs
(Fig. 4 A).
SHP-1 phosphatase might affect TCR signaling by asso-
ciating with and dephosphorylating components of the
Figure 2. Surface expression
of IR molecules on freshly iso-
lated g/d T cells. PBMCs from
nine donors were stained with
anti–pan-g/d mAbs together
with two anti-IR mAbs, and
three-color analyses were per-
formed. The figure presents the
percentage of g/d T cells reac-
tive with Q66 (anti-p140) and
HP3B1 (anti-CD94, A) or with
HP3E4 (anti-p58.1) and HP3B1
(anti-CD94,  B). Bars indicate
medians and ranges of percent-
age of total g/d T cells.
Figure 3. TNF-a release is
highly influenced by HLA class
I1 APCs when TCR-g/d is
stimulated with low doses, but
not high doses, of IPP. Two
CD941 clones, G2B2 (A and C)
and D1C55 (B and D) were
stimulated with increasing
amounts of IPP in the presence
of normal (h) or Daudi-b2 cells
(s). Anti-CD94 (n), but not an
isotype-matched irrelevant mAb
(s), partially restores TNF-a re-
lease in the presence of Daudi-
b2 cells (C and D). Similar
results were obtained in 14 inde-
pendent experiments using these
two clones and four other
CD941  g/d clones, derived from
different donors. The amount of TNF-a released by a given clone in any
given experiment was different and correlated with its activation state.
Daudi cells do not release detectable TNF-a when incubated with IPP
(not shown). Bars indicate SD.
Figure 4. TCR-g/d stimula-
tion with IPP in the presence
of HLA class I1 APC recruits
increased amounts of SHP-1
phosphatase to CD94 and to
TCR–CD3 complex and causes
tyrosine hypophosphorylation.
(A) Western blot performed with
anti–SHP-1 Abs after immuno-
precipitations carried out with
anti-CD94 (lanes 2 and 3) or an
isotype-matched irrelevant mAb
(lane 1) from g/d T cells stimu-
lated with IPP in the presence of
Daudi (lanes 1 and 2) or Daudi-
b2 APCs (lane 3). (B) Anti–SHP-1
Western blot after immunopre-
cipitation with anti-CD3 z chain
mAbs. (C) Protein tyrosine phos-
phorylation of total cell lysates is visualized by immunoblotting with an-
tiphosphotyrosine 4G10 mAb. Cells were lysed with 1% digitonin (A and
B) or with 1% NP-40 (C). Molecular mass markers are indicated on the
right in kilodaltons. Arrows indicate SHP-1 in A and B, and two hypo-
phosphorylated proteins migrating at z70 and 130 kD in C. H, Ig heavy
chain of immunoprecipitating Abs.1772 Functional Modulation of TCR-g/d by CD94
TCR–CD3 complex. In support of this hypothesis, SHP-1
was coprecipitated with the TCR–CD3 complex when g/d
T cells were cultured in the presence of Daudi-b2, but not
of Daudi APCs (Fig. 4 B). Thus, expression of MHC class I
molecules on APCs is mandatory to detect this association,
at least under the given experimental conditions. More-
over, increased amounts of SHP-1 were coprecipitated
with the TCR–CD3 complex after stimulation with IPP
(Fig. 4 B). TCR triggering might facilitate the association
of SHP-1 with components of the TCR–CD3 complex or
might initiate a cascade that facilitates the phosphorylation
of CD94, the association of SHP-1 with CD94, and thus
the recruitment of this phosphatase to the membrane (28).
Once on the membrane, SHP-1 might be recruited to the
TCR–CD3 complex more readily. This hypothesis implies
that TCR and CD94 form a functional multimolecular
complex where SHP-1 is brought into physical proximity
with its substrates, as shown in another model (30).
The increased SHP-1–TCR association may be respon-
sible for the alterations observed with some proteins in-
volved in TCR signaling. In agreement with this possibil-
ity, we found that CD94 stimulation causes a reduced
tyrosine phosphorylation of bands migrating at z70 and
130 kD (Fig. 4 C).
CD94 Engagement Affects ZAP-70 Phosphorylation, but not
ZAP-70–CD3–TCR Complex Association. To better charac-
terize which components of TCR signaling are affected by
CD94 engagement with HLA class I molecules, g/d T cells
were stimulated with IPP in the presence of Daudi or
Daudi-b2 APCs, and then ZAP-70 and the CD3 z chain
were individually precipitated and revealed using antiphos-
photyrosine mAbs (Fig. 5). In additional experiments, the
CD3–TCR complex was precipitated with anti-CD3 z
chain mAb and the coprecipitated proteins revealed with
specific antibodies (Fig. 6). These studies showed that
when both the TCR and CD94 are engaged, ZAP-70 is
hypophosphorylated (Fig. 5, A and B), although similar
amounts are associated with the CD3–TCR complex (Fig.
6 B). In the same conditions, the lck form migrating at 60
kD is less abundant (Fig. 6 A), whereas the CD3 z chain is
normally phosphorylated (Fig. 5 C). Thus, CD94 interac-
tion with HLA class I molecules causes hypophosphoryla-
tion of ZAP-70, but not of the CD3 z chain. This finding
is different from what has been observed with NK cell
clones stimulated with anti-FcgRIII mAbs. In this case in-
hibition by anti-p70 KIR mAbs leads to CD3 z dephos-
phorylation (28). This discrepancy might be due to the
used stimuli or to the type of receptors analyzed in the two
studies (FcgR and p70 KIR versus TCR-g/d and CD94).
In conclusion, in g/d T cells stimulated with nonpep-
tidic ligands, CD94 engagement by HLA class I molecules
leads to increased recruitment of SHP-1 to the TCR–CD3
complex, to reduced coprecipitation of Lck with the
TCR–CD3 complex and to hypophosphorylation of ZAP-
70. These findings may suggest that dephosphorylation of
ZAP-70 is the key event blocking downstream TCR sig-
naling.
Our data also show that the inhibitory mechanism of
CD94 is different from that of antagonist ligands. In the lat-
ter case, the CD3 immunoglobulin receptor family ty-
rosine-based activatory motifs are partially tyrosine-phos-
phorylated and ZAP-70 does not associate with the CD3 z
chain (31, 32).
An important issue concerns the implications of IR ex-
pression on the majority of g/d T cells, in particular the
Vg9/Vd2 population, which is the most abundant circulat-
ing g/d population. Vg9/Vd2 cells recognize phosphory-
lated metabolites which are commonly found in eukaryotic
and prokaryotic cells (for review see reference 33). Perhaps
the function of IR is to prevent inappropriate and poten-
tially dangerous g/d T cell activation by small quantities of
these ubiquitous compounds.
Figure 5. Tyrosine phosphorylation is affected in CD941 g/d T cells
stimulated by IPP in the presence of HLA class I1 APCs. D1C55 cells
were stimulated with IPP in the presence of normal or Daudi-b2 cells. As
control, D1C55 or Daudi cells alone were incubated with IPP. Immuno-
precipitations were carried out with anti–ZAP-70 (A and B), or anti-CD3
z chain mAbs (C). Cells were lysed with 1% NP-40 and precipitated pro-
teins were resolved by SDS-PAGE and immunoblotted with HRP-con-
jugated antiphosphotyrosine 4G10 mAbs. The blot of anti–ZAP-70 im-
munoprecipitation was stripped and reblotted with anti–ZAP-70 mAbs
(B). Arrows indicate ZAP-70 (A and B) and p21 CD3 z chain (C). H,
Heavy chain of immunoprecipitating Abs. The amount of proteins in A
and B were estimated by scanning densitometry analysis.
Figure 6. Association of Lck
but not of ZAP-70 with CD3 z
chain is diminished by engage-
ment of CD94. g/d T cells were
stimulated as described in Fig. 5,
lysed in 1% digitonin, and im-
munoprecipitated with anti-
CD3  z chain mAbs. Precipitated
proteins were resolved by SDS-
PAGE and immunoblotted with
anti-Lck mAb (A). Arrows indi-
cate the position of p56 and p60
Lck. The blot was then stripped
and reblotted with anti–ZAP-70
mAbs (B). The arrow indicates
ZAP-70. Molecular mass markers are shown at the right side of the figure
in kilodaltons. H, Heavy chain of immunoprecipitating Abs.1773 Carena et al. Brief Definitive Report
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